Cancer Therapy
17-AAG shows synergistic anticancer activity with leading chemotherapeutic agent
Published in Cancer Weekly, August 5th, 2003
Study findings demonstrate that 17-AAG and 5-fluorouracil (5-FU) administered in combination against human colon cancer cell lines results in a synergistic growth inhibiting effect.
According to study investigators, the combination of 17-AAG and 5-FU warrants further investigation as an anticancer therapy. Kosan and the National Cancer Institute (NCI) are collaborating to codevelop 17-AAG and other geldanamycin derivatives, and are planning to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2003-08-05)
More Articles from Cancer Weekly
- Oncogenes
Researchers identify secondary pathway for survival of cancer cells - RNA Interference
Scientists test new method to attack cancer - Cancer Therapy
Scientists find antitumor compounds in magnolia cones - Leukemia
Sequential chemotherapy is effective for newly diagnosed de novo AML - Oncology
Tumor-associated gangliosides modulate biological behaviors in tumors - Squamous Cancer
PD-ECGF causes head and neck cancers to cycle through growth phases quickly - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
